Author:
Guillén S,García San Miguel L,Resino S,Bellón JM,González I,Jiménez de Ory S,Muñoz-Fernández MA,Navarro ML,Gurbindo MD,de José MI,Mellado MJ,Martín-Fontelos P,Gonzalez-Tomé MI,Martinez J,Beceiro J,Roa MA,Ramos JT,
Subject
Pharmacology (medical),Infectious Diseases,Health Policy
Reference37 articles.
1. 1 Gray L , Newell ML , Thorne C et al. Fluctuations in symptoms in human immunodeficiency virus-infected children: the first 10 years of life. Pediatrics 2001; 108: 116-122.
2. 2 de Martino M , Tovo PA , Balducci M et al. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry. JAMA 2000; 284: 190-197.
3. 3 Gibb DM , Duong T , Tookey PA et al. Decline in mortality, AIDS, and hospital admissions in perinatally HIV infected children in the United Kingdom and Ireland. BMJ 2003; 327: 1019-1025.
4. 4 Sanchez JM , Ramos Amador JT , Fernandez de Miguel S et al. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children. Pediatr Infect Dis J 2003; 22: 863-867.
5. 5 Viani RM , Araneta MR , Deville JG et al. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy. Clin Infect Dis 2004; 39: 725-731.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献